Reset
Showing 3 of 3 academic articles

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations

Pedro E.N.S. Vasconcelos, MS, Ikei S. Kobayashi, MD, PhD, Susumu S. Kobayashi, MD, PhD, Daniel B. Costa, MD, PhD • JTO Clinical and Research Reports (2021)

Introduction: EGFR exon 20 insertion mutations account for 10% of all EGFR mutations and are mostly insensitive to approved EGFR tyrosine kinase inhibitors (EGFR TKIs). Novel EGFR TKIs have been developed or repurposed for these mutants. A ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jtocrr.2020.100105

Israel, Iran, and Peace in the Middle East: An Analysis of Identity Formation, Enemy Construction, and the Logic of Expansionism

Bobby Rafipoor • Strategic Research on Social Problems (2026)

Introduction This article offers a comprehensive analysis of the evolving antagonism between Israel and Iran, integrating political-sociological, historical, and geopolitical perspectives. While the immediate catalyst for this inquiry is Is...

DOAJ Open Access (DOAJ) DOI: 10.22108/srspi.2025.146689.2154